Metabolomic network reveals novel biomarkers for type 2 diabetes mellitus in the UK Biobank study
Authors' conclusion
By constructing a metabolic network that captures the complex interrelationships among circulating metabolites, our study identified total triglycerides and large HDL cholesterol as central hubs in the T2DM risk metabolome network. BCAA and GlycA emerged as alarm indicators for pre-T2DM individuals and females, respectively. Network analysis not only elucidates the topological functional roles of biomarkers but also addresses the limitations of false positives and collinearity in single-metabolite studies, offering insights for metabolic pathway research and precision interventions.
Study context
- Population
- UK Biobank participants with baseline NMR quantification of 168 circulating metabolites; T2D confirmed via medical records and ICD codes
- Participants
- 98,831 participants
- Outcome
- Incident T2D; hub metabolic biomarkers of the T2D risk network
- Follow-up
- median 12-year follow-up
Methodological detailsmetabolome-wide association study, network analysis, nuclear magnetic resonance metabolomics
- Metabolome-wide association study
- Network analysis
- Nuclear magnetic resonance metabolomics
Main finding
As reported in the abstract
- Metabolites significantly associated with T2D risk, clustered into three distinct small-world modules
- 114
Observational data: associations, not effects.
Further findings
Total branched-chain amino acids (BCAAs) in pre-T2D individuals
- Total BCAAs showed small-world network characteristics exclusively in pre-T2D individuals, suggesting a potent early indicator
GlycA in females
- GlycA showed high closeness centrality in females, implying a female-specific risk biomarker
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →